SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT...
Table of Contents United States Securities and Exchange Commission Washington...
Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK) today reported results for the third fiscal quarter ended January 31, 2014. Net sales of...
SCHEDULE 13G Amendment No. 3 HI-TECH PHARMACAL INC Common Stock Cusip #42840B101 Cusip...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of...
Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK), a specialty pharmaceuticals company, announced today that the US Food and Drug Administration...
Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK) today announced that the Texas Attorney General has agreed to close its investigation of Hi-Techβs...
Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK) today reported results for the second fiscal quarter ended October 31, 2013. Net sales of...
DJ CFA SOURCE: SEC 13F-HR FILER: AQR Capital Management LLC QUARTER ENDED: 09/30/2013 SEC RECEIVED: 11/14/2013 Up to 200 of the largest...
UNION PACIFIC CORP COM $53,089,309 341,762 23,842 OMNICOM GROUP INC COM $52,855,988 833,165 777,801 LSI CORP COM $52,558,178 6,716,700...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.